Performance of BRCA1/2 mutation prediction models in Asian Americans

Journal of Clinical Oncology

Volumn 26, Issue 29, 2008, Pages 4752-4758

  Kurian, Allison W ^a   Gong, Gail D ^a   Chun, Nicolette M ^a   Mills, Meredith A ^a   Staton, Ashley D ^a   Kingham, Kerry E ^a   Crawford, Beth B ^a   Lee, Robin ^a   Chan, Salina ^a   Donlon, Susan S ^a   Ridge, Yolanda ^a   Panabaker, Karen ^a   West, Dee W ^a   Whittemore, Alice S ^a   Ford, James M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; CANCER GENETICS; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ASIAN AMERICANS; BREAST NEOPLASMS; COMPUTER SIMULATION; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MUTATION; PREDICTIVE VALUE OF TESTS;

EID: 54249168062     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.8310     Document Type: Article

References (63)

1. Antoniou A, Pharoah PD, Narod S, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72:1117-1130, 2003
2. Chen S, Parmigiani G: Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329-1333, 2007
3. Risch HA, McLaughlin JR, Cole DE, et al: Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694-1706, 2006
4. Pal T, Permuth-Wey J, Betts JA, et al: BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104:2807-2816, 2005
5. Malone KE, Daling JR, Doody DR, et al: Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black american women ages 35 to 64 years. Cancer Res 66:8297-8308, 2006
6. John EM, Miron A, Gong G, et al: Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869-2876, 2007
7. Begg CB, Haile RW, Borg A, et al: Variation of breast cancer risk among BRCA1/2 carriers. JAMA 299:194-201, 2008
8. Nanda R, Schumm LP, Cummings S, et al: Genetic testing in an ethnically diverse cohort of high-risk women: A comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925-1933, 2005
9. Weitzel JN, Lagos V, Blazer KR, et al: Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14:1666-1671, 2005
10. Vogel KJ, Atchley DP, Erlichman J, et al: BRCA1 and BRCA2 genetic testing in Hispanic patients: Mutation prevalence and evaluation of the BRCAPRO risk assessment model. J Clin Oncol 25:4635-4641, 2007
11. Noll JE, Burbidge LA, Hall MJ, et al: Prevalence of BRCA1 and BRCA2 mutations is similar in non-Ashkenazi women of different ethnic backgrounds undergoing genetic testing. Presented at the American Society of Clinical Oncology Breast Cancer Symposium, September 7-8, 2007, San Francisco, CA
12. Berry DA, Iversen ES Jr, Gudbjartsson DF, et al: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701-2712, 2002
13. Berry DA, Parmigiani G, Sanchez J, et al: Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89:227-238, 1997
14. Frank TS, Deffenbaugh AM, Reid JE, et al: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals. J Clin Oncol 20:1480-1490, 2002
15. Antoniou AC, Pharoah PP, Smith P, et al: The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91:1580-1590, 2004
16. Evans DG, Eccles DM, Rahman N, et al: A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41:474-480, 2004
17. Barcenas CH, Hosain GM, Arun B, et al: Assessing BRCA carrier probabilities in extended families. J Clin Oncol 24:354-360, 2006
18. Euhus DM, Smith KC, Robinson L, et al: Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94:844-851, 2002
19. Parmigiani G, Chen S, Iversen ES Jr, et al: Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 147:441-450, 2007
20. Yang L, Parkin DM, Ferlay J, et al: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14:243-250, 2005
21. Yang L, Parkin DM, Li L, et al: Time trends in cancer mortality in China: 1987-1999. Int J Cancer 106:771-783, 2003
22. Son BH, Kwak BS, Kim JK, et al: Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg 141:155-160, 2006
23. Buell P: Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51:1479-1483, 1973
24. LeMarchand L, Kolonel LN, Nomura AM: Breast cancer survival among Hawaii Japanese and Caucasian women: Ten-year rates and survival by place of birth. Am J Epidemiol 122:571-578, 1985
25. Goodman MJ: Breast cancer in multi-ethnic populations: The Hawaii perspective. Breast Cancer Res Treat 18:S5-S9, 1991 (suppl)
26. Maskarinec G, Nagata C, Shimizu H, et al: Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int J Cancer 102:29-33, 2002
27. Pike MC, Kolonel LN, Henderson BE, et al: Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: Risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev 11:795-800, 2002
28. Suter NM, Ray RM, Hu YW, et al: BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer Epidemiol Biomarkers Prev 13:181-189, 2004
29. Hu Z, Li WF, Liu XY, et al: 5589del8: The recurrent mutation of BRCA1 gene in Chinese breast cancer patients [in Japanese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24:378-381, 2007
30. Hu Z, Wu J, Liu CH, et al: The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives. Hum Mutat 22:104, 2003
31. Hu Z, Wu J, Lu JS, et al: Analysis of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives [in Japanese]. Zhonghua Zhong Liu Za Zhi 26:657-659, 2004
32. Kwong A, Wong LP, Chan KY, et al: Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family. Fam Cancer [Epub ahead of print on July 27, 2007]
33. Aida H, Takakuwa K, Nagata H, et al: Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1. Clin Cancer Res 4:235-240, 1998
34. De Leon Matsuda ML, Liede A, Kwan E, et al: BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. Int J Cancer 98:596-603, 2002
35. Ahn SH, Son BH, Yoon KS, et al: BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Lett 245:90-95, 2007
36. Emi M, Matsushima M, Katagiri T, et al: Multiplex mutation screening of the BRCA1 gene in 1000 Japanese breast cancers. Jpn J Cancer Res 89:12-16, 1998
37. Han SH, Lee KR, Lee DG, et al: Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Clin Genet 70:496-501, 2006
38. Ikeda N, Miyoshi Y, Yoneda K, et al: Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91:83-88, 2001
39. Patmasiriwat P, Bhothisuwan K, Sinilnikova OM, et al: Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer. Hum Mutat 20:230, 2002
40. Liede A, Narod SA: Hereditary breast and ovarian cancer in Asia: Genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20:413-424, 2002
41. Rao NY, Hu Z, Li WF, et al: Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat [Epub ahead of print on March 16, 2008]
42. National Comprehensive Cancer N: Genetic/ Familial High-Risk Assessment: Breast and Ovarian. V. 1.2007. http://www.nccn.org/professionals/physician_gls/ PDF/genetics_screening.pdf
43. Struewing JP, Abeliovich D, Peretz T, et al: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200, 1995
44. Robson M, Dabney MK, Rosenthal G, et al: Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Genet Test 1:47-51, 1997
45. Díez O, Osorio A, Robledo M, et al: Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients. Br J Cancer 79:1302-1303, 1999
46. de la Hoya M, Osorio A, Godino J, et al: Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing. Int J Cancer 97:466-471, 2002
47. Myriad Genetics Laboratories: BRACAnalysis Technical Specifications (updated August 4, 2006). Salt Lake City, UT, Myriad Genetics Laboratories, 2006
48. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44:837-845, 1988
49. Marroni F, Aretini P, D'Andrea E, et al: Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations. Eur J Hum Genet 12:899-906, 2004
50. Antoniou AC, Durocher F, Smith P, et al: BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 8:R3, 2006
51. Capalbo C, Ricevuto E, Vestri A, et al: Improving the accuracy of BRCA1/2 mutation prediction: Validation of the novel country-customized IC software. Eur J Hum Genet 14:49-54, 2006
52. Fasching PA, Bani MR, Nestle-Kramling C, et al: Evaluation of mathematical models for breast cancer risk assessment in routine clinical use. Eur J Cancer Prev 16:216-224, 2007
53. James PA, Doherty R, Harris M, et al: Optimal selection of individuals for BRCA mutation testing: A comparison of available methods. J Clin Oncol 24:707-715, 2006
54. Marroni F, Aretini P, D'Andrea E, et al: Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet 41:278-285, 2004
55. Oros KK, Ghadirian P, Maugard CM, et al: Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent. Clin Genet 70:320-329, 2006
56. Ottini L, Masala G, D'Amico C, et al: BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: A population-based study in Italy. Cancer Res 63:342-347, 2003
57. Stuppia L, Di Fulvio P, Aceto G, et al: BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy. Hum Mutat 22:178-179, 2003
58. Katki HA: Effect of misreported family history on Mendelian mutation prediction models. Biometrics 62:478-487, 2006
59. Weitzel JN, Lagos VI, Cullinane CA, et al: Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297:2587-2595, 2007
60. Tryggvadottir L, Sigvaldason H, Olafsdottir GH, et al: Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. J Natl Cancer Inst 98:116-122, 2006
61. Parkin DM, Whelan SL, Ferlay J, et al: Cancer incidence in five continents, Vol VII. Lyon, France, IARC, 1997
62. Eng C, Brody LC, Wagner TM, et al: Interpreting epidemiological research: Blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet 38:824-833, 2001
63. Kurian AW, Chun NM, Mills MA, et al: BRCA1/2 mutations and cancer risk in Asian-Americans. J Clin Oncol 25:568s; 2007 (suppl; abstr 10512)